We are live on ! Find out more
NPCE icon

Neuropace
NPCE

41 hedge funds and large institutions have $156M invested in Neuropace in 2023 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,700% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 1

75% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 8

64% more funds holding

Funds holding: 25 → 41 (+16)

11% less capital invested

Capital invested by funds: $176M → $156M (-$19.7M)

12.24% less ownership

Funds ownership: 69.89% → 57.65% (-12%)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
41
Holders Change
+16
Holders Change %
+64%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
14
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$20.1M
2
KLC
Kent Lake Capital
Nevada
+$770K
3
Renaissance Technologies
Renaissance Technologies
New York
+$511K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$337K
5
Jane Street
Jane Street
New York
+$294K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.9M
2
EI
EAM Investors
California
-$602K
3
NCM
Nantahala Capital Management
Connecticut
-$369K
4
SCM
Soleus Capital Management
Connecticut
-$263K
5
BCM
Bridgeway Capital Management
Texas
-$209K
Name Holding Trade Value Shares
Change 		Change in
Stake
Man Group
26
Man Group
United Kingdom
$199K +$154K +19,298 New
TC
27
TownSquare Capital
Utah
$164K +$126K +15,859 New
Walleye Capital
28
Walleye Capital
New York
$148K +$114K +14,320 New
Marshall Wace
29
Marshall Wace
United Kingdom
$146K +$113K +14,171 New
Barclays
30
Barclays
United Kingdom
$144K +$25K +3,132 +29%
CSS
31
Cubist Systematic Strategies
Connecticut
$118K +$91K +11,415 New
JP Morgan Chase
32
JP Morgan Chase
New York
$117K +$90.6K +11,360 New
VF
33
Virtu Financial
New York
$111K +$85.8K +10,764 New
FAIM
34
Financial Advocates Investment Management
Washington
$103K – – –
Lazard Asset Management
35
Lazard Asset Management
New York
$40K +$31.3K +3,929 New
PAS
36
Point72 Asia (Singapore)
Singapore
$2.65K +$2.05K +257 New
TRCT
37
Tower Research Capital (TRC)
New York
$2.6K +$2.01K +252 New
Osaic Holdings
38
Osaic Holdings
Arizona
$2.4K +$1.86K +233 New
Federated Hermes
39
Federated Hermes
Pennsylvania
$1.2K -$2.46K -308 -73%
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$1K +$909 +114 +2,850%
Wells Fargo
41
Wells Fargo
California
$835 +$56 +7 +9%
UBS Group
42
UBS Group
Switzerland
– -$535 -55 Closed
1
2

NPCE Hedge Fund Activity: Q4 2023 in Review

41 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Neuropace (NPCE) for Q4 2023, worth a combined $156M — down 11% from $176M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new NPCE positions and 1 closed out — a net gain of 17 holders — while 14 added to existing stakes and 8 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $20.1M. The largest seller was Fidelity Investments, cutting an estimated $1.9M.

  • 41 institutional investors held Neuropace (NPCE) as of Q4 2023, up from 25 in Q3 2023.
  • Funds reported $156M of Neuropace stock for Q4 2023, down 11% quarter-over-quarter.
  • 18 funds opened new Neuropace positions in Q4 2023 and 1 closed out, a net change of +17 holders.
  • The largest Neuropace buyer in Q4 2023 was Morgan Stanley, an estimated $20.1M added.
  • The largest Neuropace seller in Q4 2023 was Fidelity Investments, an estimated $1.9M sold.

Based on aggregated 13F filings for Q4 2023.